Revolution Medicines CEO Mark A. Goldsmith reports disposal of common shares worth $16.87 million

Reuters2026/08/26 10:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Revolution Medicines CEO Mark A. Goldsmith exercised stock options for 80,000 shares at USD 4.73 on Aug. 21, 2026.
He sold 80,000 shares the same day in open-market transactions at weighted-average prices near USD 207.23 to USD 212.08.
Directly held common stock fell to 267,330 shares following the transactions.
Two revocable trusts reported small same-day sales, leaving 61,424 shares in each trust.
A separate revocable living trust reported 594,060 shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000387), on August 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Revolution Medicines CEO Mark A. Goldsmith reports disposal of common shares worth $16.87 million

You may also like

Crypto prices